Abraham Lieberman

Most-cited papers

Interaction of pergolide with central dopaminergic receptors.
M. Goldstein, Abraham Lieberman, J. Y. Lew, Taku Asano +2 more
1980Proceedings of the National Academy of Sciences of the United States of America136 citations Open access
Semantic Scholar
Bromocriptine in Parkinson disease.
Abraham Lieberman, M. Goldstein
1985Pharmacological Reviews81 citations
Semantic Scholar
Binding interactions of ergot alkaloids with monoaminergic receptors in the brain.
M. Goldstein, J. Y. Lew, F. Hata, Abraham Lieberman
1978Gerontology45 citations
Semantic Scholar
Dopaminephilic properties of ergot alkaloids.
M. Goldstein, J. Y. Lew, S. Nakamura, A. Battista +2 more
1978Federation proceedings41 citations
Semantic Scholar
The affinities of ergot compounds for dopamine agonist and dopamine antagonist receptor sites.
M. Goldstein, J. Y. Lew, A. Sauter, Abraham Lieberman
1980Advances in biochemical psychopharmacology21 citations
Semantic Scholar
Bromocriptine, lergotrile: the antiparkinsonian efficacy and the interaction with monoaminergic receptors.
M. Goldstein, Abraham Lieberman, Arthur F. Battista, J. Y. Lew +1 more
1978Pharmacology21 citations
Semantic Scholar
Treatment of Parkinson's disease with dopamine agonists: A review
Abraham Lieberman, A. Neophytides, M. Kupersmith, Ira Casson +5 more
1979American Journal of the Medical Sciences15 citations
Semantic Scholar
Treatment of Parkinson's disease with lergotrile mesylate.
Abraham Lieberman, Eli Estey, M. Kupersmith, G. Gopinathan +1 more
1977Journal of the American Medical Association (JAMA)15 citations
Semantic Scholar
Management of Levodopa Failures: The Use of Dopamine Agonists
Abraham Lieberman, G. Gopinathan, A. Neophytides, M. Goldstein
1986Clinical neuropharmacology6 citations
Semantic Scholar